Target intelligence / Profile preview

Hemoglobin (heme iron binding site) (Hb)

Target
Hb
Molecular classification
Metalloprotein, Oxygen transporter, Other (globin protein)
01

Overview

The heme binding site of hemoglobin refers to the iron atom (Fe²⁺) within the heme prosthetic group in each hemoglobin subunit, which reversibly binds oxygen. Each hemoglobin molecule has four such sites, allowing binding and transport of up to four oxygen molecules. The binding occurs via a coordinate covalent bond between oxygen and the iron at the heme's sixth coordination position, stabilized by histidine residues. Oxygen binding is cooperative—as each oxygen binds, the affinity for the next increases, producing a sigmoidal (S-shaped) oxygen dissociation curve. This allows efficient oxygen loading in the lungs and release in tissues. The heme site is also the target for toxic gases and some drugs, making it a pharmacological and toxicological target[1][5][8][9].

Other names
Hemoglobin heme siteHemoglobin O₂ binding siteOxyhemoglobin site
02

Mechanism of action

Oxygen: reversible binding to heme iron (Fe²⁺) as the sixth ligand Carbon monoxide: competitive binding to heme iron with higher affinity, preventing O₂ binding[1][5] Nitric oxide: competitive binding, can cause vasodilation and modulate O₂ delivery Some drugs (e.g., methylene blue): oxidoreductase activity restores hemoglobin iron to the ferrous state for O₂ binding in methemoglobinemia

03

Biological functions

Oxygen transportCarbon dioxide transport (indirectly)Acid-base balance (indirectly, via the Bohr effect)
04

Disease associations

AnemiaCarbon monoxide poisoningMethemoglobinemiaSickle cell disease (structural and functional hemoglobin disorders)Hypoxic conditions
05

Safety considerations

Toxic ligands (e.g., CO, cyanide) can occupy the heme site and prevent O₂ deliveryAltered binding (e.g., by methemoglobinemia, pH, 2,3-DPG, mutations) impairs O₂ delivery[5]Risk of oxidative damage and hemolysis in variant hemoglobins
06

Interacting drugs

Carbon monoxide (CO) (toxin, not therapeutic)

4 more in the full profile.

07

Biomarkers

Oxyhemoglobin saturation (SpO₂, SaO₂)Carboxyhemoglobin (for CO poisoning)Methemoglobin (for methemoglobinemia)Hemoglobin levels (Hb)

Beyond the preview

Go deeper on Hemoglobin (heme iron binding site) (Hb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin (heme iron binding site) (Hb).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call